20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T25140 | BCH 2763 | BCH2763,BCH-2763 | |
BCH 2763 is an effective, selective bifunctional thrombin inhibitor that blocks both the anion binding exosite and the active catalytic site. | |||
T11820 | LAT1-IN-1 | BCH | Apoptosis , Others |
LAT1-IN-1 (BCH) (BCH) significantly inhibit cellular uptake of amino acids and mTOR phosphorylation, which induces the suppression of cancer growth and apoptosis. is a selective and competitive inhibitor of large neutral... | |||
T0682 | Lamivudine | GR109714X,BCH-189 | HIV Protease , Reverse Transcriptase |
Lamivudine (BCH-189) is a reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease. | |||
T8647 | BCH001 | DNA/RNA Synthesis | |
BCH001 is a specific small-molecule inhibitor of PAPD5. | |||
T33891 | PBI-1393 | PBI1393,BCH1393,BCH 1393,BCH-1393,PBI 1393 | |
PBI-1393 can be used as an enhancer for Th1 type cytokine production and primary T cell activation. | |||
T28833 | SPD-756 | SPD 756,BCH13520,BCH-13520,BCH 13520 | |
SPD-756, a nucleoside reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection. | |||
T29149 | VX 759 | VCH759,BCH27759,VX-759,VX759,VCH-759,BCH-27759 | |
VX 759, a nonstructural protein 5B (NS5B) inhibitor, is used potentially for the treatment of HCV infection. | |||
T17175 | Troxacitabine | BCH-4556,SGX-145,SGX145,SPD-758,BCH4556,beta-L-OddC | Others |
Troxacitabine, a DNA polymerase inhibitor, is potentially used for the treatment of acute myeloid leukemia (AML). In comparison with gemcitabine, troxacitabine was equally active against MiaPaCa and was more efficacious ... | |||
T61969 | AChE/BChE-IN-10 | AChR , AChE | |
AChE/BChE-IN-10 is a potent dual inhibitor of AChE and BChE with IC50 values of 0.176, and 0.47 μM, respectively. AChE/BChE-IN-10 exhibits good blood brain barrier permeability. AChE/BChE-IN-10 can inhibit Aβ-aggregation... | |||
T60891 | AChE/BChE/MAO-B-IN-1 | MAO , AChE | |
AChE/BChE/MAO-B-IN-1 is a reversible, non-time-dependent inhibitor of AChE, BChE and MAO-B that crosses the blood-brain barrier and exhibits inhibitory effects on hAChE, hBChE and hMAO-B with IC50s of 7.31, 0.56 and 26.1... | |||
T62336 | BChE-IN-3 | ||
BChE-IN-3 is a selective, selective, time-dependent, pseudo-irreversible inhibitor of BChE butyrylcholinesterase (IC50: 56.9 nM).BChE-IN-3 exhibits borderline reversible (time-independent) inhibition of AChE acetylcholin... | |||
T60831 | AChE/BChE-IN-3 hydrochloride | ||
AChE/BChE-IN-3 (BMC-1) hydrochloride is an AChE and BChE dual inhibitor. The IC50 values of AChE/BChE-IN-3 against equine serum BChE (eqBChE) and electric eel AChE (elAChE) is 0.383 μM and 6.08 μM, respectively [1]. | |||
T78799 | BChE/HDAC6-IN-1 | HDAC | |
BChE/HDAC6-IN-1 is a dual BChE/HDAC6 inhibitor that exhibits potent and selective inhibition with IC50 values of 4 nM for BChE and 8.9 nM for HDAC6. It demonstrates efficacy in alleviating cognitive deficits in an Aβ1–42... | |||
T61669 | BChE-IN-4 | ||
BChE-IN-4 is a highly potent inhibitor of the enzyme butyrylcholinesterase, capable of crossing the blood-brain barrier. It effectively reduces learning and memory impairments resulting from a deficiency in cholinergic a... | |||
T75511 | BChE-IN-10 | ||
BChE-IN-10 (compound 6), isolated from Bletilla striata, is a potent mixed-type butyrylcholinesterase (BChE) inhibitor exhibiting an IC50 value of 6.4 μM. It is utilized in Alzheimer's disease (AD) research [1]. | |||
T78695 | BChE-IN-16 | ||
BChE-IN-16 (compound 87) is a potent inhibitor of human butyrylcholinesterase (hBChE) exhibiting an inhibition concentration half-maximum (IC50) of 3.8 nM. It demonstrates low cytotoxicity and potential for central nervo... | |||
T62274 | AChE/BChE-IN-2 | ||
AChE/BChE-IN-2 (Compound 13b) is a potent inhibitor of AChE/BChE with IC50 values of 0.96 ± 0.14 μM and 1.23 ± 0.23 μM for AChE and BChE, respectively. | |||
T73184 | BChE-IN-15 | ||
BChE-IN-15 is a compound characterized as a pseudo-irreversible, covalent inhibitor of butyrylcholinesterase (BChE), demonstrating potent activity with an inhibitory concentration (IC50) of 1.76 nM against human BChE (hB... | |||
T62504 | BChE-IN-8 | ||
BChE-IN-8 (compound 20) is an orally active BChE (butyrylcholinesterase) inhibitor that crosses the blood-brain barrier and acts on eqBChE (IC50: 0.15 nM), hBChE (IC50: 45.2 nM). BChE-IN-8 can be used in the study of Alz... | |||
T13242 | UbcH5c-IN-1 | Others | |
UbcH5c-IN-1 is a selective small-molecule Ubiquitin-conjugating enzyme UbcH5c inhibitor (Kd: 283 nM for E2 UbcH5c-IN-1 by covalent binding with Cys85). |